skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Material Type:
Article
Add to My Research

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Nature Medicine, 2021-05, Vol.27 (5), p.917-924 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/s41591-021-01318-5 ;PMID: 33772244

Full text available

2
COVID-19 Research: Lessons from Non-Human Primate Models
Material Type:
Article
Add to My Research

COVID-19 Research: Lessons from Non-Human Primate Models

Vaccines (Basel), 2021-08, Vol.9 (8), p.886 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9080886 ;PMID: 34452011

Full text available

3
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Material Type:
Article
Add to My Research

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

BioRxiv, 2021-02

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.02.12.430472

Digital Resources/Online E-Resources

4
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Material Type:
Article
Add to My Research

SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation

The EMBO journal, 2021-12, Vol.40 (24), p.e108944-n/a [Peer Reviewed Journal]

2021 The Authors ;2021 The Authors. ;2021 EMBO ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.2021108944 ;PMID: 34601723

Full text available

5
SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation
Material Type:
Article
Add to My Research

SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation

bioRxiv, 2021-08

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.06.11.448011v2 ;DOI: 10.1101/2021.06.11.448011

Digital Resources/Online E-Resources

Searching Remote Databases, Please Wait